NCT01095393View on ClinicalTrials.gov

National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)

CompletedOBSERVATIONAL
Enrollment

12,500

Participants

Timeline

Start Date

September 1, 2009

Primary Completion Date

December 13, 2016

Study Completion Date

December 31, 2019

Conditions
Rheumatoid Arthritis
Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
collaborator

National Data Bank for Rheumatic Diseases (NDB)

OTHER

lead

UCB Pharma

INDUSTRY

NCT01095393 - National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs) | Biotech Hunter | Biotech Hunter